LEMAITRE VASCULAR, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M | $129.4M | $117.2M |
| Cost of Revenue | — | $71.1M | $69.0M | $66.4M | $56.8M | $53.0M | $44.7M | $37.4M |
| Gross Profit | — | $178.5M | $150.9M | $127.0M | $104.9M | $101.4M | $84.6M | $79.9M |
| Gross Margin | — | 71.5% | 68.6% | 65.7% | 64.9% | 65.7% | 65.4% | 68.1% |
| Operating Expenses | ||||||||
| Research & Development | — | $14.1M | $15.7M | $17.0M | $13.3M | $11.8M | $10.1M | $9.3M |
| SG&A Expense | — | $42.0M | $36.3M | $31.8M | $28.7M | $25.5M | $22.5M | $19.1M |
| Operating Income | — | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M | $28.8M | $21.2M |
| Operating Margin | — | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% | 22.3% | 18.1% |
| Interest Expense | — | $5.2M | $205.0K | $0 | $0 | $2.2M | $1.3M | $0 |
| Pretax Income | — | $75.2M | $56.9M | $39.5M | $27.5M | $34.3M | $27.4M | $21.7M |
| Income Tax Expense | — | $17.5M | $12.8M | $9.4M | $6.9M | $7.4M | $6.1M | $3.7M |
| Net Income | — | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M | $21.2M | $17.9M |
| Net Margin | — | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% |
| EPS (Basic) | — | $2.55 | $1.96 | $1.36 | $0.94 | $1.27 | $1.05 | $0.91 |
| EPS (Diluted) | — | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 | $0.88 |
| Shares Outstanding (Basic) | 22.8M | 22.6M | 22.5M | 22.2M | 22.0M | 21.2M | 20.2M | 19.8M |
| Shares Outstanding (Diluted) | 22.8M | 22.9M | 22.8M | 22.4M | 22.2M | 21.5M | 20.5M | 20.3M |
| Dividends Per Share | — | $0.80 | $0.64 | $0.56 | $0.50 | $0.44 | $0.38 | $0.34 |